• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

即使在接受吸入一氧化氮治疗的婴儿中,动脉pH值对氧合的影响依然存在。

The Effect of Arterial pH on Oxygenation Persists Even in Infants Treated with Inhaled Nitric Oxide.

作者信息

Barton Aimee M, Abubakar M Kabir, Berg Jennifer, Keszler Martin

机构信息

Department of Pediatrics, Georgetown University Hospital, 3800 Reservoir Road NW, M3400, Washington, DC 20007, USA.

出版信息

Pulm Med. 2011;2011:189205. doi: 10.1155/2011/189205. Epub 2011 Jul 3.

DOI:10.1155/2011/189205
PMID:21766014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3135073/
Abstract

Objective. To validate the empiric observation that pH has an important effect on oxygenation in infants receiving iNO. Study Design. Demographics, ventilator settings, arterial blood gases (ABG), and interventions for up to 96 hours of life were extracted from the charts of 51 infants receiving iNO. Need for ECMO and survival to discharge were noted. Mean blood pressure (MBP) and mean airway pressure (MAP) were recorded. The arterial/alveolar (a/A) ratio was used as the primary outcome. Analysis was by simple linear regression and multiple linear regression analyses and Fisher's exact test. pH responsiveness was arbitrarily defined as a correlation coefficient (CC) of >0.40 with P < 0.05. Results. Mean gestational age was 38.8 weeks and mean birth weight was 3300 g. All patients had clinical diagnosis of PPHN. Clear responsiveness to pH was found in 31/51 infants. MAP and MBP did not correlate with a/A ratio. Three responders had a critical pH > 7.55. Of 11 patients requiring ECMO, only 3 exhibited responsiveness at any time in their course. Three responders required ECMO. Conclusion. This small study suggests that failure or inability to optimize pH may account for observed unresponsiveness to iNO. Maintaining a pH > 7.5 using hyperventilation is not recommended.

摘要

目的。验证pH值对接受吸入一氧化氮(iNO)治疗的婴儿氧合有重要影响这一经验性观察结果。研究设计。从51例接受iNO治疗的婴儿病历中提取出生人口统计学资料、呼吸机设置、动脉血气(ABG)以及出生后96小时内的干预措施。记录是否需要体外膜肺氧合(ECMO)以及出院存活率。记录平均血压(MBP)和平均气道压(MAP)。动脉/肺泡(a/A)比值用作主要结局指标。采用简单线性回归、多元线性回归分析和Fisher精确检验进行分析。pH反应性被任意定义为相关系数(CC)>0.40且P<0.05。结果。平均胎龄为38.8周,平均出生体重为3300克。所有患者均有持续性肺动脉高压(PPHN)的临床诊断。51例婴儿中有31例对pH有明显反应。MAP和MBP与a/A比值无关。3例有反应者的临界pH>7.55。在11例需要ECMO的患者中,只有3例在病程中的任何时候表现出反应性。3例有反应者需要ECMO。结论。这项小型研究表明,未能优化pH值或无法优化pH值可能是观察到的对iNO无反应的原因。不建议使用过度通气维持pH>7.5。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8daf/3135073/5614075a951b/PM2011-189205.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8daf/3135073/f404a4eb62f5/PM2011-189205.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8daf/3135073/63f21f3456bc/PM2011-189205.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8daf/3135073/5614075a951b/PM2011-189205.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8daf/3135073/f404a4eb62f5/PM2011-189205.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8daf/3135073/63f21f3456bc/PM2011-189205.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8daf/3135073/5614075a951b/PM2011-189205.003.jpg

相似文献

1
The Effect of Arterial pH on Oxygenation Persists Even in Infants Treated with Inhaled Nitric Oxide.即使在接受吸入一氧化氮治疗的婴儿中,动脉pH值对氧合的影响依然存在。
Pulm Med. 2011;2011:189205. doi: 10.1155/2011/189205. Epub 2011 Jul 3.
2
Inhaled nitric oxide and gentle ventilation in the treatment of pulmonary hypertension of the newborn--a single-center, 5-year experience.吸入一氧化氮与轻度通气治疗新生儿肺动脉高压——单中心5年经验
J Perinatol. 2002 Sep;22(6):435-41. doi: 10.1038/sj.jp.7210761.
3
Randomized, controlled trial of low-dose inhaled nitric oxide in the treatment of term and near-term infants with respiratory failure and pulmonary hypertension.低剂量吸入一氧化氮治疗足月和近足月呼吸衰竭及肺动脉高压婴儿的随机对照试验
Pediatrics. 1999 Nov;104(5 Pt 1):1089-94. doi: 10.1542/peds.104.5.1089.
4
Nitric oxide for respiratory failure in infants born at or near term.一氧化氮用于足月或近足月出生婴儿的呼吸衰竭。
Cochrane Database Syst Rev. 2006 Oct 18(4):CD000399. doi: 10.1002/14651858.CD000399.pub2.
5
Airway function in infants treated with inhaled nitric oxide for persistent pulmonary hypertension.吸入一氧化氮治疗持续性肺动脉高压的婴儿的气道功能
Pediatr Pulmonol. 2008 Mar;43(3):224-35. doi: 10.1002/ppul.20733.
6
Hypoxic respiratory failure in term newborns: clinical indicators for inhaled nitric oxide and extracorporeal membrane oxygenation therapy.足月儿缺氧性呼吸衰竭:吸入一氧化氮和体外膜肺氧合治疗的临床指标
J Crit Care. 2005 Sep;20(3):288-93. doi: 10.1016/j.jcrc.2005.05.011.
7
Nitric oxide for the treatment of preterm infants with severe RDS and pulmonary hypertension.一氧化氮用于治疗重度呼吸窘迫综合征和肺动脉高压的早产儿。
Pediatr Pulmonol. 2017 Nov;52(11):1461-1468. doi: 10.1002/ppul.23843.
8
Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. The Neonatal Inhaled Nitric Oxide Study Group (NINOS).吸入一氧化氮与先天性膈疝婴儿的低氧性呼吸衰竭。新生儿吸入一氧化氮研究组(NINOS)。
Pediatrics. 1997 Jun;99(6):838-45. doi: 10.1542/peds.99.6.838.
9
Inhaled nitric oxide for neonates with persistent pulmonary hypertension of the newborn in the CINRGI study: time to treatment response.CINRGI 研究中吸入一氧化氮治疗新生儿持续肺动脉高压:从治疗到起效的时间。
BMC Pediatr. 2019 Jan 12;19(1):17. doi: 10.1186/s12887-018-1368-4.
10
Persistent Pulmonary Hypertension of the Newborn with D-transposition of the Great Arteries: Management and Prognosis.新生儿持续肺动脉高压合并大动脉转位:管理与预后
Congenit Heart Dis. 2016 May;11(3):239-44. doi: 10.1111/chd.12304. Epub 2015 Nov 11.

引用本文的文献

1
A nomogram prediction model for early death in patients with persistent pulmonary hypertension of the newborn.新生儿持续性肺动脉高压患者早期死亡的列线图预测模型
Front Cardiovasc Med. 2022 Dec 22;9:1077339. doi: 10.3389/fcvm.2022.1077339. eCollection 2022.
2
Evidence-Based Guidelines for Acute Stabilization and Management of Neonates with Persistent Pulmonary Hypertension of the Newborn.证据为基础的指南:新生儿持续肺动脉高压的急性稳定化和管理。
Am J Perinatol. 2023 Oct;40(14):1495-1508. doi: 10.1055/a-1711-0778. Epub 2021 Dec 1.

本文引用的文献

1
Inhaled nitric oxide in the treatment of moderate persistent pulmonary hypertension of the newborn: a randomized controlled, multicenter trial.吸入一氧化氮治疗新生儿中度持续性肺动脉高压:一项随机对照多中心试验。
J Perinatol. 2003 Mar;23(2):98-103. doi: 10.1038/sj.jp.7210878.
2
Inhaled nitric oxide in neonates with persistent pulmonary hypertension.吸入一氧化氮治疗新生儿持续性肺动脉高压
Lancet. 2001 Jan 13;357(9250):118-20. doi: 10.1016/S0140-6736(00)03548-0.
3
Inhaled nitric oxide reduces the need for extracorporeal membrane oxygenation in infants with persistent pulmonary hypertension of the newborn.
吸入一氧化氮可减少新生儿持续性肺动脉高压患儿对体外膜肺氧合的需求。
Crit Care Med. 2000 Nov;28(11):3722-7. doi: 10.1097/00003246-200011000-00031.
4
Clinical approach to inhaled nitric oxide therapy in the newborn with hypoxemia.
J Pediatr. 2000 Jun;136(6):717-26.
5
Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group.低剂量一氧化氮疗法治疗新生儿持续性肺动脉高压。临床吸入一氧化氮研究组。
N Engl J Med. 2000 Feb 17;342(7):469-74. doi: 10.1056/NEJM200002173420704.
6
Inhaled nitric oxide, oxygen, and alkalosis: dose-response interactions in a lamb model of pulmonary hypertension.吸入一氧化氮、氧气与碱中毒:肺动脉高压羔羊模型中的剂量-反应相互作用
Pediatr Pulmonol. 1999 Jul;28(1):3-11. doi: 10.1002/(sici)1099-0496(199907)28:1<3::aid-ppul2>3.0.co;2-s.
7
Cerebral blood flow during treatment for pulmonary hypertension.肺动脉高压治疗期间的脑血流量。
Arch Dis Child Fetal Neonatal Ed. 1999 Jan;80(1):F30-3. doi: 10.1136/fn.80.1.f30.
8
Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure.吸入一氧化氮用于足月及近足月低氧性呼吸衰竭婴儿。
N Engl J Med. 1997 Feb 27;336(9):597-604. doi: 10.1056/NEJM199702273360901.
9
Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group.吸入一氧化氮与新生儿持续性肺动脉高压。吸入一氧化氮研究小组。
N Engl J Med. 1997 Feb 27;336(9):605-10. doi: 10.1056/NEJM199702273360902.
10
Efficacy and neurologic outcome of profound hypocapneic alkalosis for the treatment of persistent pulmonary hypertension in infancy.深度低碳酸血症性碱中毒治疗婴儿持续性肺动脉高压的疗效及神经学转归
J Pediatr. 1984 Sep;105(3):457-61. doi: 10.1016/s0022-3476(84)80029-3.